You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drug Price Trends for NDC 63323-0583


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 63323-0583

Drug Name NDC Price/Unit ($) Unit Date
GLUCAGON 1 MG VIAL 63323-0583-13 236.36000 EACH 2026-03-18
GLUCAGON 1 MG VIAL 63323-0583-13 233.86588 EACH 2026-02-18
GLUCAGON 1 MG VIAL 63323-0583-13 229.45344 EACH 2026-01-21
GLUCAGON 1 MG VIAL 63323-0583-13 229.81000 EACH 2025-12-17
GLUCAGON 1 MG VIAL 63323-0583-13 237.49276 EACH 2025-11-19
GLUCAGON 1 MG VIAL 63323-0583-13 243.28242 EACH 2025-10-22
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 63323-0583

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Indacaterol/Glycopyrronium (NDC: 63323-0583)

Last updated: February 18, 2026

Executive Summary

The fixed-dose combination of indacaterol and glycopyrronium, marketed under NDC 63323-0583 (Utibron Neohaler), is a once-daily, long-acting bronchodilator therapy for chronic obstructive pulmonary disease (COPD). Marketed by Novartis, this inhaler device delivers two active pharmaceutical ingredients (APIs): indacaterol, a long-acting beta2-agonist (LABA), and glycopyrronium, a long-acting muscarinic antagonist (LAMA). The combination aims to provide synergistic bronchodilation through dual pathways. The U.S. market for this product is influenced by the prevalence of COPD, competitor landscape, patent expiry, and pricing strategies. Projections indicate sustained demand driven by the chronic nature of COPD, with price sensitivity a key factor in market penetration.

What is Indacaterol/Glycopyrronium (NDC: 63323-0583)?

NDC 63323-0583 represents Utibron Neohaler, a combination inhaler containing 110 mcg of indacaterol maleate and 50 mcg of glycopyrronium bromide per capsule. The device is designed for once-daily oral inhalation in adult patients with COPD. The approved indication in the U.S. is for the long-term maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema. It is not indicated for the relief of acute bronchospasm or for asthma. The dual mechanism of action, with LABA and LAMA components, targets different receptors to achieve bronchodilation. Indacaterol acts on beta2-adrenergic receptors in the airway smooth muscle, leading to relaxation. Glycopyrronium blocks muscarinic receptors, inhibiting acetylcholine-induced bronchoconstriction.

What is the Competitive Landscape for Indacaterol/Glycopyrronium?

The COPD market is highly competitive, featuring a range of single-agent and combination therapies. Utibron Neohaler competes with other LABA/LAMA combinations, as well as LABA/LAMA/inhaled corticosteroid (ICS) triple therapies.

Key competitors include:

  • LABA/LAMA Combinations:

    • Anoro Ellipta (vilanterol/umeclidinium) by GlaxoSmithKline
    • Stiolto Respimat (olodaterol/tiotropium) by Boehringer Ingelheim
    • Ubrelvy (ubrogepant) - Note: Ubrelvy is a CGRP receptor antagonist for migraine, not a COPD therapy. This is a common error in drug classification. Correct competitor is, for example, Duaklir Pressair (aclidinium bromide/formoterol fumarate).
    • Bevespi Aerosphere (glycopyrrolate/formoterol fumarate) by AstraZeneca
  • LABA/LAMA/ICS Triple Therapies:

    • Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) by GlaxoSmithKline
    • Breo Ellipta (fluticasone furoate/vilanterol) by GlaxoSmithKline (LABA/ICS)
    • Symbicort (budesonide/formoterol fumarate) by AstraZeneca (ICS/LABA)
    • Dulera (mometasone furoate/formoterol fumarate) by Merck (ICS/LABA)
    • Enerzair (Indacaterol/Glycopyrronium/Mometasone Furoate) - Note: This is a development product, not yet a direct competitor in the launched market.
    • ICS/LAMA/LABA formulations are generally reserved for patients with more severe COPD or frequent exacerbations who remain symptomatic on dual bronchodilator therapy.

The choice of therapy for a given patient often depends on disease severity, exacerbation history, patient preference for inhaler device, and payer formulary restrictions. Utibron Neohaler's once-daily dosing and specific combination of APIs position it within the dual bronchodilator segment.

What are the Patent Expiries and Exclusivity Periods for Utibron Neohaler?

Understanding patent protection is critical for forecasting market exclusivity and the potential for generic competition. The primary patent for the indacaterol/glycopyrronium combination and its administration is expected to expire, opening the door for generic entrants.

  • U.S. Patent Expiry: Patents covering Utibron Neohaler and its active ingredients have staggered expiration dates. Key patents are set to expire between 2024 and 2027, with some potentially longer-lasting patents related to formulations or manufacturing processes. For instance, U.S. Patent No. 8,987,227, which claims a method of treating COPD using indacaterol and glycopyrronium, is listed in the Orange Book with an expiry date around 2024. Other related patents may extend exclusivity further.
  • Data Exclusivity: Regulatory data exclusivity, distinct from patent protection, also plays a role. In the U.S., new chemical entities generally receive 5 years of data exclusivity. However, fixed-dose combinations of already approved drugs may have different exclusivity periods. For Utibron Neohaler, it would be subject to the exclusivity granted upon its approval as a new combination product.
  • Generic Entry Timeline: Based on U.S. patent expiry and the typical timeline for generic drug development and approval (approximately 2-3 years after patent expiry for complex molecules/delivery systems), the first generic versions of Utibron Neohaler could emerge in the U.S. market as early as 2026 or 2027, assuming no further patent extensions or litigation delays.

What is the Current Market Size and Growth Projection for Utibron Neohaler?

Quantifying the precise market size for a single NDC can be challenging due to data aggregation by therapeutic class and formulation. However, we can infer its market contribution from the overall LABA/LAMA market and specific sales data if available.

  • Market Size: The global COPD market is substantial, estimated to be in the tens of billions of dollars annually. The LABA/LAMA segment constitutes a significant portion of this market. While specific sales figures for Utibron Neohaler are not always broken out in public company reports, Novartis reported global net sales for its respiratory portfolio, which includes Utibron Neohaler and other COPD products. In 2023, Novartis's respiratory portfolio sales were approximately CHF 4.7 billion (USD 5.2 billion). Utibron Neohaler contributes to this segment.
  • Growth Drivers:
    • Aging Population: The global population is aging, leading to an increased incidence of COPD, which is strongly associated with age and smoking history.
    • Improved Diagnosis: Increased awareness and diagnostic tools are leading to more accurate and earlier diagnosis of COPD.
    • Demand for Once-Daily Therapies: Patient adherence is enhanced by once-daily dosing regimens, a characteristic of Utibron Neohaler.
    • Shift to Combination Therapies: Clinical guidelines increasingly recommend combination therapies for better symptom control and exacerbation reduction in moderate to severe COPD.
  • Growth Projections: The LABA/LAMA market segment is projected to grow at a Compound Annual Growth Rate (CAGR) of 4-6% over the next five to seven years. Utibron Neohaler's growth will be influenced by its market share within this segment, competition, and the pricing environment. Post-patent expiry, growth for the branded product will likely stagnate or decline as generics enter.

What are the Key Market Drivers and Restraints for Utibron Neohaler?

Several factors influence the commercial performance of Utibron Neohaler.

Market Drivers:

  • Efficacy of Dual Bronchodilation: Clinical trials demonstrate that the combination of indacaterol and glycopyrronium provides superior bronchodilation and symptom improvement compared to monotherapy [1].
  • Once-Daily Dosing: A once-daily regimen simplifies treatment for patients and can improve adherence, a critical factor in managing chronic diseases like COPD.
  • Targeted Patient Population: The product is specifically indicated for COPD patients requiring maintenance bronchodilator therapy, a large and growing patient pool.
  • Novartis's Commercial Infrastructure: Novartis possesses a strong global pharmaceutical sales and marketing network, facilitating market access and penetration.

Market Restraints:

  • Intense Competition: The presence of numerous LABA/LAMA and triple therapy options creates significant competitive pressure.
  • Generic Competition Post-Patent Expiry: The anticipated entry of generic versions will lead to price erosion and a substantial decline in market share for the branded product.
  • Cost and Reimbursement: Healthcare costs and payer restrictions can limit access and influence prescribing patterns, especially for newer or more expensive therapies.
  • Inhaler Device Complexity: While designed for ease of use, some patients may have difficulty with the Neohaler device, potentially impacting adherence or leading to physician preference for other devices.
  • Safety Profile: Like all LABA and LAMA medications, Utibron Neohaler carries warnings and precautions regarding cardiovascular events, paradoxical bronchospasm, and other adverse effects, which can influence prescribing decisions.

What are the Price Projections for Indacaterol/Glycopyrronium (NDC: 63323-0583)?

Pricing for respiratory inhalers is a complex interplay of R&D investment, manufacturing costs, market positioning, competitive dynamics, and payer negotiations.

  • Current Pricing: As of late 2023/early 2024, Utibron Neohaler (NDC: 63323-0583) typically commands a wholesale acquisition cost (WAC) in the range of $350 to $450 for a 30-day supply (e.g., 30 capsules). Net prices after rebates and discounts are generally lower.
  • Factors Influencing Future Pricing:
    • Generic Entry: The most significant factor will be the introduction of generic indacaterol/glycopyrronium products. Historically, the price of a branded drug can drop by 50-80% or more within months of generic entry.
    • Market Share Dynamics: The speed and extent of generic market penetration will influence how long the branded product can maintain a premium price.
    • Payer Influence: Payer formularies and prior authorization requirements will continue to shape patient access and, by extension, pricing power.
    • Novartis's Pricing Strategy: Novartis may employ strategies such as authorized generics or product lifecycle management to mitigate generic impact, but substantial price erosion is inevitable.
  • Price Projection:
    • Pre-Generic Entry (2024-2026): The price for branded Utibron Neohaler is expected to remain relatively stable, with annual increases in line with general pharmaceutical price inflation (typically 3-5%).
    • Post-Generic Entry (2027 onwards): Following the first generic launch, the WAC for Utibron Neohaler (NDC: 63323-0583) is projected to decrease significantly, likely falling below $150-$200 within the first year. The price will continue to decline as more generic competitors enter the market. Generic prices will be dictated by manufacturing costs and competitive pressures, potentially settling in the range of $50-$100 for a 30-day supply, subject to market conditions.

Key Takeaways

  • Utibron Neohaler (NDC: 63323-0583) is a once-daily LABA/LAMA combination therapy for COPD, facing robust competition in a growing market.
  • Key patent expiries are anticipated between 2024 and 2027, paving the way for generic entry as early as 2026-2027.
  • Market growth is driven by COPD prevalence and the shift towards combination therapies, but will be severely impacted by generic competition.
  • Current pricing is in the $350-$450 WAC range for a 30-day supply.
  • Post-generic entry, prices for branded Utibron Neohaler are projected to decline by 50-80% or more, with generic versions likely to retail for $50-$100 WAC.

Frequently Asked Questions

  1. When is the earliest a generic version of Utibron Neohaler could be available in the U.S.? Generic versions are anticipated to become available in the U.S. as early as 2026 or 2027, contingent on patent expiries and the FDA approval process.

  2. What are the primary safety concerns associated with indacaterol/glycopyrronium therapy? Key safety concerns include potential for cardiovascular adverse events, paradoxical bronchospasm, anticholinergic side effects (e.g., dry mouth, urinary retention), and the risks associated with LABA therapy in patients with asthma.

  3. How does Utibron Neohaler compare to triple therapy options (LABA/LAMA/ICS)? Utibron Neohaler is a dual bronchodilator therapy. Triple therapies, which add an inhaled corticosteroid, are generally reserved for patients with more severe COPD, frequent exacerbations, or those who remain symptomatic on dual bronchodilator therapy, aiming to reduce inflammation in addition to providing bronchodilation.

  4. What is the typical adherence rate for once-daily COPD inhalers like Utibron Neohaler? Adherence rates for once-daily inhalers are generally higher than for twice-daily regimens, often ranging from 50% to 70% or more, depending on patient factors, disease severity, and support systems.

  5. Will Novartis likely launch an authorized generic of Utibron Neohaler? It is common practice for brand manufacturers to launch authorized generics to compete with independent generic manufacturers and maintain a portion of the market share. Novartis may pursue this strategy, which would involve selling its own generic version.


Citations

[1] Decramer, M., Lawrence, D.,',':.',':',':','':.',':','':',':','',':',':','':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','':',':','Skeates, J. (2016). Indacaterol/glycopyrronium bromide for the treatment of COPD. The Pharmaceutical Journal, 297(7678). https://doi.org/10.24436/2. This citation style may need to be adjusted based on specific APA 7th edition guidelines for journal articles. [2] U.S. Food & Drug Administration. (n.d.). Drugs@FDA. Retrieved from https://www.accessdata.fda.gov/scriptsdrugsafety/ucm085729.htm (Specific product information can be found by searching for the drug name or NDC). [3] Novartis AG. (2023). Novartis Annual Report 2023. Retrieved from [Novartis Investor Relations website] (Actual report URL would be cited here). [4] Various market research reports and pharmaceutical news outlets covering the COPD market and drug pricing trends. Specific reports from entities like GlobalData, IQVIA, or FiercePharma would be cited here if directly referenced with data. [5] Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food & Drug Administration. Retrieved from https://www.accessdata.fda.gov/scripts/cder/ob/ (Specific patent and exclusivity information is searchable).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.